Evidence map›Paper›PMID 35747753›Full record

ArticleFrontiers in pharmacology2022

Remedial Aspect of Zinc Oxide Nanoparticles Against

Sinouvassane Djearamane, Zhe Chi Loh, Jun Jie Lee, Ling Shing Wong, Ranjithkumar Rajamani, Priscy Alfredo Luque, Piyush Kumar Gupta, Sharolynne Xiao Tong Liang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Sinouvassane DjearamaneDepartment of Biomedical Science, Universiti Tunku Abdul Rahman (UTAR), Kampar, Malaysia.
Zhe Chi LohDepartment of Biomedical Science, Universiti Tunku Abdul Rahman (UTAR), Kampar, Malaysia.
Jun Jie LeeDepartment of Biomedical Science, Universiti Tunku Abdul Rahman (UTAR), Kampar, Malaysia.
Ling Shing WongFaculty of Health and Life Sciences, INTI International University, Nilai, Malaysia.
Ranjithkumar RajamaniViyen Biotech LLP, Coimbatore, India.
Priscy Alfredo LuqueFaculty of Engineering, Architecture, and Design, Autonomous University of Baja California, Mexicali, Mexico.
Piyush Kumar GuptaDepartment of Life Sciences, School of Basic Sciences and Research, Sharda University, Greater Noida, India.
Sharolynne Xiao Tong LiangDepartment of Biomedical Science, Universiti Tunku Abdul Rahman (UTAR), Kampar, Malaysia.
Universiti Tunku Abdul Rahman · MYINTI International University · MYSharda University · INUniversidad Autónoma de Baja California · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zinc oxide nanoparticles (ZnO NPs) have been widely used in biomedical applications due to their high biocompatibility and low toxicity to humans. The present work aimed to investigate the antibacterial effects of different concentrations of ZnO NPs on two opportunistic pathogens,

Indexed as

antibacterial agentE. faecalisgrowth inhibitionS. marcescenszinc oxide nanoparticles

Identifiers

PMID35747753
PMCPMC9209744
OpenAlexW4281739735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.